Accumulating evidence has revealed that CaMKIIγ functions as an important molecular switch in several oncogenic signaling pathways, including nuclear factor kappa B (NF-κB), Wnt/β-catenin, ERK, AKT, and STAT3, and thus is closely implicated in the pathogenesis of cancer [55,56,57,58]. This evidence concerns the gene STAT3 and cancer.